The opioid antagonist naltrexone improves murine inflammatory bowel disease

J Immunotoxicol
April 2008
https://pubmed.ncbi.nlm.nih.gov/18569389/

Leonard Weinstock, MD - Celiac Disease (2017 Conference) (LDN, low dose naltrexone)

Celiac disease is a remarkable condition. It can present in so many different ways and have so many symptoms. What we're going to try is to hone down on the autoimmune conditions that are associated with it, which don't get as much attention in the literature as they should.

Nasha Winters, ND - Navigating the Narrative (2017 Conference) (LDN, low dose naltrexone)

Dr Nasha Winters speaks from experience when she talks about Cancer and how to be proactive in preventing and/or combating it. In her youth she was diagnosed with a terminal Cancer, but discovered the life changes that would turn it around. 

Leonard Weinstock, MD - Inflammatory Bowel Disease II (2017 Conference) (LDN, low dose naltrexone)

Inflammatory bowel disease is a condition that we see as gastroenterologists on a daily basis. I'm Dr. Weinstock. I'd like to review inflammatory bowel disease, what the traditional approaches are, and some of the newer changes that we've seen with low dose naltrexone. Here are my disclosures.